Addex Therapeutics Company Leadership
ADXN Stock | USD 8.15 0.62 8.23% |
Addex Therapeutics employs about 23 people. The company is managed by 7 executives with a total tenure of roughly 54 years, averaging almost 7.0 years of service per executive, having 3.29 employees per reported executive. Analysis of Addex Therapeutics' management performance can provide insight into the firm performance.
Addex |
Addex Therapeutics' Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Addex Therapeutics' future performance. Based on our forecasts, it is anticipated that Addex will maintain a workforce of about 200000 employees by January 2025.Addex Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.6171) % which means that it has lost $0.6171 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2629) %, meaning that it created substantial loss on money invested by shareholders. Addex Therapeutics' management efficiency ratios could be used to measure how well Addex Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 10th of December 2024, Return On Tangible Assets is likely to grow to -2.16. In addition to that, Return On Capital Employed is likely to grow to -5.6. At this time, Addex Therapeutics' Intangible Assets are very stable compared to the past year. As of the 10th of December 2024, Other Assets is likely to grow to about 66 K, while Total Assets are likely to drop about 4.4 M.As of the 10th of December 2024, Common Stock Shares Outstanding is likely to grow to about 78 M, though Net Loss is likely to grow to (17.8 M).
Addex Therapeutics Workforce Comparison
Addex Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 632. Addex Therapeutics holds roughly 23.0 in number of employees claiming about 4% of equities under Health Care industry.
The company has Profit Margin (PM) of 5.0 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is normal as compared to the sector avarege. Similarly, it shows Operating Margin (OM) of (7.8) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $7.8. Addex Therapeutics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Addex Therapeutics Price Series Summation is a cross summation of Addex Therapeutics price series and its benchmark/peer.
Addex Therapeutics Notable Stakeholders
An Addex Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Addex Therapeutics often face trade-offs trying to please all of them. Addex Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Addex Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Timothy Dyer | CEO CoFounder | Profile | |
Werner Henrichi | Consultant | Profile | |
Mikhail Kalinichev | Head Science | Profile | |
JeanPhilippe Rocher | Head Chemistry | Profile | |
Roger MD | Chief Director | Profile | |
Lnaic Teyssdou | Head Finance | Profile | |
Robert Lutjens | Head Biology | Profile |
About Addex Therapeutics Management Performance
The success or failure of an entity such as Addex Therapeutics often depends on how effective the management is. Addex Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Addex management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Addex management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (2.27) | (2.16) | |
Return On Capital Employed | (5.90) | (5.60) | |
Return On Assets | (2.27) | (2.16) | |
Return On Equity | (9.22) | (8.75) |
Addex Therapeutics Workforce Analysis
Traditionally, organizations such as Addex Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Addex Therapeutics within its industry.Addex Therapeutics Manpower Efficiency
Return on Addex Therapeutics Manpower
Revenue Per Employee | 70.1K | |
Revenue Per Executive | 230.4K | |
Net Loss Per Employee | 459K | |
Net Loss Per Executive | 1.5M | |
Working Capital Per Employee | 58.3K | |
Working Capital Per Executive | 191.6K |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (21.86) | Revenue Per Share 1.2 | Quarterly Revenue Growth (0.82) | Return On Assets (0.62) | Return On Equity (1.26) |
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.